Currently out of the existing stock ratings of William Tanner, 9 are a HOLD (23.08%), 28 are a BUY (71.79%), 2 are a SELL (5.13%).

William Tanner

Work Performance Price Targets & Ratings Chart

Analyst William Tanner, carries an average stock price target met ratio of 57.19% that have a potential upside of 36.41% achieved within 508 days.

William Tanner’s has documented 80 price targets and ratings displayed on 11 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on NVAX, Novavax at 14-Jun-2021.

Wall Street Analyst William Tanner

Analyst best performing recommendations are on NVAX (NOVAVAX).
The best stock recommendation documented was for NVAX (NOVAVAX) at 7/7/2020. The price target of $148 was fulfilled within 21 days with a profit of $43.44 (41.55%) receiving and performance score of 19.78.

Average potential price target upside

of $27.72 (42.21%) on NVAX (NOVAVAX).
of $23.77 (57.99%) on ARNA (ARENA PHARMACEUTICALS).
of $21.31 (66.26%) on PRTA (PROTHENA PLC).

NVAX Novavax AIMT Aimmune Therapeutics ALKS Alkermes Plc JAZZ Jazz Pharmaceuticals PLC PRTA Prothena plc TXMD TherapeuticsMD AMAG AMAG Pharmaceuticals ARNA Arena Pharmaceuticals CBAY Cymabay Therapeu NLTX Neoleukin Therapeutics RGLS Regulus Therapeutics

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Alec Stranahan (BAML)